Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · Texas | Bone graft & orthobiologics · Florida | |
|---|---|---|
| Surgeons, 2024 | 52 | 34 |
| Medicare fee-for-service cases | 1,980 | 1,353 |
| Growth since 2019 (Medicare FFS) | −11%/yr | −8.3%/yr |
| Forecast cases (Medicare FFS) | 1,960 in 2030 | 1,490 in 2030 |
| Forecast growth | −0.1%/yr to 2030 | +1.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.9 | 0.6 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 3% (+2 pts since 2019) | 6% (+5 pts since 2019) |
| Cases per surgeon | 38 | 40 |
| Top 10 surgeons' share | 40% | 56% |
| Surgeons growing | 1 | 3 |
| New since the base year | 7 | 2 |
| Likely to stop billing it | 9 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $9,010 | $24K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.